InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,778.05
(
-0.03%
)
Post# of 160314
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TechKim

Send PM Follow Ignore
Followers 86
Posts 25803
Boards Moderated 0
Alias Born 09/15/2003

TechKim

Re: None

Friday, 04/06/2018 8:13:25 AM

Friday, April 06, 2018 8:13:25 AM

Post# of 160314
PGNX pocket change play. The delayed news from the FDA had no mention of efficacy or safety concerns. It is already on the fast track program.

Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for AZEDRA® (iobenguane I 131)

"The extension is the result of the submission of additional Chemistry, Manufacturing, and Controls (CMC) information by Progenics, which required additional time for FDA review. The standard three-month extension is not related to the efficacy or safety data of AZEDRA.
https://ih.advfn.com/p.php?pid=nmona&article=77014971

Note to traders:
Patience is affordable with the time delay to find a good dip. In my opinion.

1/2 cent Vancouver penny mooching pirates!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up